Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Douglas Nowacki

Orthopaedic Surgery of the Spine Ocean, NJ Medical Doctor

NPI 1518302660 CMS profile 4223743

1200 Eagle Ave, Ocean, NJ 07712

Open in the dashboard

General payments

$17,401

227 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Douglas Nowacki of Ocean, NJ is reported in the CMS Open Payments database as having received $17,401 across 227 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 55th percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,137 28
2024 General $1,704 38
2023 General $2,791 25
2022 General $2,287 26
2021 General $1,024 24
2020 General $609 15
2019 General $7,850 71

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Douglas Nowacki
  • Orthopaedic Surgery of the Spine median
  • Middle half of Orthopaedic Surgery of the Spine
  • National median

In program year 2025, general payments to Douglas Nowacki were reported at $1,137. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.

Show as a table
Year Douglas Nowacki Orthopaedic Surgery of the Spine median Middle half National median
2019 $7,850 $2,106 $337–$18,608 $163
2020 $609 $1,213 $156–$15,082 $114
2021 $1,024 $1,834 $271–$15,617 $132
2022 $2,287 $2,015 $320–$17,036 $149
2023 $2,791 $1,925 $336–$14,599 $160
2024 $1,704 $2,110 $341–$12,483 $164
2025 $1,137 $2,061 $347–$14,651 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $4,259 39 payments
  2. Medtronic, Inc. $3,707 42 payments
  3. NuVasive, Inc. $3,059 49 payments
  4. Medtronic USA, Inc. $1,873 12 payments
  5. Globus Medical, Inc. $1,146 3 payments
  6. Providence Medical Technology, Inc. $879 21 payments
  7. Alphatec Spine, Inc $638 12 payments
  8. DePuy Synthes Sales Inc. $433 6 payments
  9. Djo, LLC $239 5 payments
  10. Boston Scientific Corporation $173 2 payments
  11. Other $996 36 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $11,182 201 payments
  2. Travel and Lodging $5,841 21 payments
  3. Education $339 3 payments
  4. Entertainment $39 2 payments
Products named General payments · program years 2019–2025
  1. XLIF $1,959 15 payments
  2. CD HORIZON $1,848 10 payments
  3. O-ARM $1,667 12 payments
  4. ExcelsiusGPS Robotic Navigation System $1,102 2 payments
  5. TRITANIUM $1,058 8 payments
  6. MAZOR X SYSTEM $856 10 payments
  7. ANCHOR L $798 4 payments
  8. AERO $798 4 payments
  9. ARIA $798 4 payments
  10. Xvision $714 10 payments
  11. Other $8,072 160 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

25

Median for Orthopedic Surgery: 203

Drug cost

$307

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 13 $190
Methylprednisolone Generic 12 $117

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 43 billing codes

Paid by Medicare

$35,643

Medicare's payments for the services billed

Medicare patients

87

Average age 74

Services billed

215

55 women, 32 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 37%
Diabetes 36%
Osteoporosis 30%
Chronic kidney disease 26%
Depression 25%
Atrial fibrillation 23%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

227 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery of the Spine in New Jersey

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record